Nevirapine decision causes government AIDS head “sleepless nights”
Government’s head of HIV/AIDS, Dr Nono Simelela, says she has been “spending sleepless nights asking what we are to do with mother-to-child-transmission if we can’t have nevirapine”.
“I have 80 000 women on this programme. I have to have an answer for them,” Simelela told media shortly before the opening of the first South African AIDS conference in Durban on Sunday (3 August).
This follows the Medicines Control Council’s (MCC) decision last week to reject the Ugandan study which declared the drug safe and effective in preventing mother-to-child HIV transmission.
Simelela said the Department of Health was “informed about the MCC decision at the same time as it hit the media”, and that it was “not privy to correspondence between the MCC and nevirapine’s manufacturer, Boehringer Ingelheim”.
“We still have to formulate our Plan B. The Minister needs to meet with the MECs to consider the decision. We have a responsibility in terms of the Constitutional Court to ensure PMTCT,” said Simelela.
The Constitutional Court ruled last year that government had to offer nevirapine or a suitable alternative to pregnant women with HIV.
The MCC has given Boehringer Ingelheim 90 days to provide other evidence that its drug is safe for PMTC, something the manufacturer says it doubts it will be able to do.
Conference chairperson Prof Jerry Coovadia said the nevirapine decision had come as a shock, but that such shocks could be avoided if there was a body that brought policy makers and scientists together.
Coovadia said there was a danger of “democratic anarchy” unless government had recourse to “the best available science”.
UN Special Envoy on AIDS, Stephen Lewis, said that most African countries were using nevirapine for their PMTCT programmes.
“Africa is entering a desperate and difficult period as the [HIV] infections become full-blown AIDS, and there is a sense that the worst is still to come,” said Lewis, who has just completed a tour of Uganda, Rwanda and Mozambique.
African countries were “obsessed with treatment” as there was a “desperate feeling that they need to keep people alive [yet] had reached a point of no return”.
Lewis said that while changing male sexual behaviour had to be addressed, this would take generations as there was “nothing more obdurate”.
However, the empowerment of women “can be done more rapidly” and there was “no time to lose to stop losing all the women that we are at present”. – Health-e News Service.
Author
Kerry Cullinan is the Managing Editor at Health-e News Service. Follow her on Twitter @kerrycullinan11
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Nevirapine decision causes government AIDS head “sleepless nights”
by Kerry Cullinan, Health-e News
August 4, 2003